Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
The classification of Heart Defect Closure Devices includes ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices and LAA Closure Devices. And the proportion of Amplatzer PFO Occluder in 2017 is about 33%, and the proportion is in decreasing trend from 2013 to 2017. LAA Closure Devices with the growth rate about 18%, in 2017 the market share is nearly 22%.
Heart Defect Closure Devices is widely used in hospitals and clinics. The most proportion of Heart Defect Closure Devices is used in Hospital, and the proportion in 2017 is 61%. Europe is the largest consumption place, with a consumption market share nearly 30% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 27%.
Market competition is not intense. Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates and Starway are the leaders of the industry, with high-end customers.
The report offers detailed coverage of Heart Defect Closure Devices industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Heart Defect Closure Devices by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Heart Defect Closure Devices market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Heart Defect Closure Devices market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort
At the same time, we classify Heart Defect Closure Devices according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Market by Application
Hospitals
Clinics
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Heart Defect Closure Devices market for the forecast period 2021 - 2025?
• What are the driving forces in the Heart Defect Closure Devices market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Heart Defect Closure Devices industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?